Relevant bibliographies by topics / Viral / Journal articles
To see the other types of publications on this topic, follow the link: Viral.

Journal articles on the topic 'Viral'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Viral.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

US, A. Dürdal. "Viral Superantigens." Mikrobiyoloji Bulteni 50, no. 3 (July 29, 2016): 491–504. http://dx.doi.org/10.5578/mb.24250.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Garcia-Iglesias, Jaime, Maurice Nagington, and Peter Aggleton. "Viral times, viral memories, viral questions." Culture, Health & Sexuality 23, no. 11 (October 19, 2021): 1465–69. http://dx.doi.org/10.1080/13691058.2021.1976564.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kaplún, Gabriel. "Viral y vital. Ciudadanía, educación y comunicación." Question/Cuestión 1, junio (June 6, 2020): e349. http://dx.doi.org/10.24215/16696581e349.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Deiman, Birgit A. L. M., and Cornelis W. A. Pleij. "Pseudoknots: A Vital Feature in Viral RNA." Seminars in Virology 8, no. 3 (1997): 166–75. http://dx.doi.org/10.1006/smvy.1997.0119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kara, İsmail Hamdi. "Acute viral hepatitis." Turkiye Aile Hekimligi Dergisi 12, no. 1 (2008): 39–43. http://dx.doi.org/10.2399/tahd.08.039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rainetová, Petra. "Viral intestinal infections - viral gastroenteritides." Pediatrie pro praxi 18, no. 1 (April 4, 2017): 44–49. http://dx.doi.org/10.36290/ped.2017.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

McGill, Paul E. "Viral infections: α-viral arthropathy." Baillière's Clinical Rheumatology 9, no. 1 (February 1995): 145–50. http://dx.doi.org/10.1016/s0950-3579(05)80151-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fujinami, R., and T. Weber. "Viral neuroimmunology/Viral neuropathogenesis I." Journal of Neurovirology 8, no. 3 (January 2002): 16–17. http://dx.doi.org/10.1080/13550280290049840.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bauckhage, Christian, Fabian Hadiji, and Kristian Kersting. "How Viral Are Viral Videos?" Proceedings of the International AAAI Conference on Web and Social Media 9, no. 1 (August 3, 2021): 22–30. http://dx.doi.org/10.1609/icwsm.v9i1.14598.

Full text
Abstract:
Within only a few years after the launch of video sharing platforms, viral videos have become a pervasive Internet phenomenon. Yet, notwithstanding growing scholarly interest, the suitability of the viral metaphor seems not to have been studied so far. In this paper, we therefore investigate the attention dynamics of viral videos from the point of view of mathematical epidemiology. We introduce a novel probabilistic model of the progression of infective diseases and use it to analyze time series of YouTube view counts and Google searches. Our results on a data set of almost 800 videos show that their attention dynamics are indeed well accounted for by our epidemic model. In particular, we find that the vast majority of videos considered in this study show very high infection rates.
APA, Harvard, Vancouver, ISO, and other styles
10

Kara, İsmail Hamdi. "Acute viral hepatitis C." Turkiye Aile Hekimligi Dergisi 12, no. 2 (2008): 89–94. http://dx.doi.org/10.2399/tahd.08.089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

KARPAGAVALLI.G, KARPAGAVALLI G., and B. MANUEL PINTO. "Viral Marketing- An Insight." International Journal of Scientific Research 3, no. 4 (June 1, 2012): 12–13. http://dx.doi.org/10.15373/22778179/apr2014/231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Yoshizumi, Marc O. "Viral retinitis in systemic viral infections." Current Opinion in Ophthalmology 2, no. 2 (April 1991): 190–96. http://dx.doi.org/10.1097/00055735-199102020-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

L.B, Dr Jasmin. "Viral Conjunctivitis- A Clinical Study." Journal of Medical Science And clinical Research 05, no. 04 (April 30, 2017): 21085–91. http://dx.doi.org/10.18535/jmscr/v5i4.212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Jain, Dr Ritika. "Viral Marketing: Power or Menace." Indian Journal of Applied Research 3, no. 5 (October 1, 2011): 403–5. http://dx.doi.org/10.15373/2249555x/may2013/123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

WM*, Dos Santos. "Resveratrol’s Action against Viral Infections." Advances in Pharmacology and Clinical Trials 9, no. 2 (May 10, 2024): 1–3. http://dx.doi.org/10.23880/apct-16000236.

Full text
Abstract:
The biological activity of resveratrol (3,5,4’-trihydroxy-trans-stilbene) has been the subject of extensive study in the treatment of various diseases due to its anti-inflammatory, antioxidant and anticancer activities, as well as its minimal toxicity and side effects. It has been widely accepted that resveratrol also has antiviral activities. In this mini-review, we summarize resveratrol’s antiviral mechanisms. Since viral infections are often accompanied by inflammation, the TLRs/NF-κB signaling pathways are key and common molecular mechanisms for resveratrol to exert anti-inflammatory and antiviral effects.
APA, Harvard, Vancouver, ISO, and other styles
16

Fournier, P. E., R. Charrel, and D. Raoult. "Viral Endocarditis or Simple Viral Disseminated Infection?" Clinical Infectious Diseases 53, no. 12 (October 25, 2011): 1298. http://dx.doi.org/10.1093/cid/cir681.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Cosby, L., and H. J. von Giesen. "Viral vectors/Viral latency (II)/Antiretroviral therapeutics." Journal of Neurovirology 8, no. 3 (January 2002): 37–38. http://dx.doi.org/10.1080/13550280290049958.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Schang, Luis M., Amy Rosenberg, and Priscilla A. Schaffer. "Roscovitine, a Specific Inhibitor of Cellular Cyclin-Dependent Kinases, Inhibits Herpes Simplex Virus DNA Synthesis in the Presence of Viral Early Proteins." Journal of Virology 74, no. 5 (March 1, 2000): 2107–20. http://dx.doi.org/10.1128/jvi.74.5.2107-2120.2000.

Full text
Abstract:
ABSTRACT We have previously shown that two inhibitors specific for cellular cyclin-dependent kinases (cdks), Roscovitine (Rosco) and Olomoucine (Olo), block the replication of herpes simplex virus (HSV). Based on these results, we demonstrated that HSV replication requires cellular cdks that are sensitive to these drugs (L. M. Schang, J. Phillips, and P. A. Schaffer. J. Virol. 72:5626–5637, 1998). We further established that at least two distinct steps in the viral replication cycle require cdks: transcription of immediate-early (IE) genes and transcription of early (E) genes (L. M. Schang, A. Rosenberg, and P. A. Schaffer, J. Virol. 73:2161–2172, 1999). Since Rosco inhibits HSV replication efficiently even when added to infected cells at 6 h postinfection, we postulated that cdks may also be required for viral functions that occur after E gene expression. In the study presented herein, we tested this hypothesis directly by measuring the efficiency of viral replication, viral DNA synthesis, and expression of several viral genes during infections in which Rosco was added after E proteins had already been synthesized. Rosco inhibited HSV replication, and specifically viral DNA synthesis, when the drug was added at the time of release from a 12-h phosphonoacetic acid (PAA)-induced block in viral DNA synthesis. Inhibition of DNA synthesis was not a consequence of inhibition of expression of IE or E genes in that Rosco had no effect on steady-state levels of two E transcripts under the same conditions in which it inhibited viral DNA synthesis. Moreover, viral DNA synthesis was inhibited by Rosco even in the absence of protein synthesis. In a second series of experiments, the replication of four HSV mutants harboring temperature-sensitive mutations in genes essential for viral DNA replication was inhibited when Rosco was added at the time of shift-down from the nonpermissive to the permissive temperature. Viral DNA synthesis was inhibited by Rosco under these conditions, whereas expression of viral E genes was not affected. We conclude that cellular Rosco-sensitive cdks are required for replication of viral DNA in the presence of viral E proteins. This requirement may indicate that HSV DNA synthesis is functionally linked to transcription, which requires cdks, or that both viral transcription and DNA replication, independently, require viral or cellular factors activated by Rosco-sensitive cdks.
APA, Harvard, Vancouver, ISO, and other styles
19

Dönmez, Ahmet Erdem, and Doruk Yılmaz. "Viral encephalopathy and retinopathy in fishes." Ege Journal of Fisheries and Aquatic Sciences 35, no. 3 (September 15, 2018): 335–42. http://dx.doi.org/10.12714/egejfas.2018.35.3.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Goyal, Ravi, Rajni Bala, Rakesh K. Sindhu, Mehrukh Zehravi, Reecha Madaan, Sarker Ramproshad, Banani Mondal, Abhijit Dey, Md Habibur Rahman, and Simona Cavalu. "Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2." Nanomaterials 12, no. 9 (May 1, 2022): 1530. http://dx.doi.org/10.3390/nano12091530.

Full text
Abstract:
Since ancient times, plants have been used for their medicinal properties. They provide us with many phytomolecules, which serve a synergistic function for human well-being. Along with anti-microbial, plants also possess anti-viral activities. In Western nations, about 50% of medicines were extracted from plants or their constituents. The spread and pandemic of viral diseases are becoming a major threat to public health and a burden on the financial prosperity of communities worldwide. In recent years, SARS-CoV-2 has made a dramatic lifestyle change. This has promoted scientists not to use synthetic anti-virals, such as protease inhibitors, nucleic acid analogs, and other anti-virals, but to study less toxic anti-viral phytomolecules. An emerging approach includes searching for eco-friendly therapeutic molecules to develop phytopharmaceuticals. This article briefly discusses numerous bioactive molecules that possess anti-viral properties, their mode of action, and possible applications in treating viral diseases, with a special focus on coronavirus and various nano-formulations used as a carrier for the delivery of phytoconstituents for improved bioavailability.
APA, Harvard, Vancouver, ISO, and other styles
21

Ramadhani, Ghina. "Viral Marketing." IMOVICCON Conference Proceeding 1, no. 1 (July 3, 2019): 123–30. http://dx.doi.org/10.37312/imoviccon.v1i1.14.

Full text
Abstract:
Increasing use of the internet by millennials is a phenomenon that needs to be adapted to. The advertising-marketing world is no exception. Responds to the phenomenon has been varying, for example there’s a new category for advertising media besides Above The Line and Below The Line; Through The Line Media. Through The Line occurred to define internet media which has the quality of both above the line and below the line medias. Another form of adaptation to this situation exists in the form of marketing strategies; that is viral marketing. Viral marketing is a strategy that is only relevant in internet media. This paper will try to explain the kind of impact made from this marketing strategy, and its effectiveness on millennial target audiences by using some case studies on the brand, Go-Jek.
APA, Harvard, Vancouver, ISO, and other styles
22

Greenberg, Stephen B. "Viral Pneumonia." Infectious Disease Clinics of North America 5, no. 3 (September 1991): 603–21. http://dx.doi.org/10.1016/s0891-5520(20)30408-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Fairchild, Patrick G., and Neil R. Blacklow. "Viral Diarrhea." Infectious Disease Clinics of North America 2, no. 3 (September 1988): 677–84. http://dx.doi.org/10.1016/s0891-5520(20)30218-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Balistreri, William F. "Viral Hepatitis." Emergency Medicine Clinics of North America 9, no. 2 (May 1991): 365–99. http://dx.doi.org/10.1016/s0733-8627(20)30492-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Mader, Thomas H., and R. Doyle Stulting. "VIRAL KERATITIS." Infectious Disease Clinics of North America 6, no. 4 (December 1992): 831–49. http://dx.doi.org/10.1016/s0891-5520(20)30485-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Hunter, Philip. "Viral taxonomy." EMBO reports 18, no. 10 (September 6, 2017): 1693–96. http://dx.doi.org/10.15252/embr.201744982.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Malhotra, A., and L. R. Krilov. "Viral Croup." Pediatrics in Review 22, no. 1 (January 1, 2001): 5–12. http://dx.doi.org/10.1542/pir.22-1-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Dietz, Mary. "Viral Cytokines." Stem Cells 18, no. 1 (January 2000): 69–72. http://dx.doi.org/10.1634/stemcells.18-1-69.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Berry, Arnold J. "Viral Hepatitis." Anesthesiology Clinics of North America 7, no. 4 (December 1989): 771–94. http://dx.doi.org/10.1016/s0889-8537(21)00171-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Singh, Virendra, and RajivR Singh. "Viral hepatitis." Indian Journal of Medical Research 142, no. 4 (2015): 499. http://dx.doi.org/10.4103/0971-5916.169234.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Barroso-González, Jonathan, Laura García-Expósito, Isabel Puigdomènech, Laura de Armas-Rillo, José-David Machado, Julià Blanco, and Agustín Valenzuela-Fernández. "Viral infection." Communicative & Integrative Biology 4, no. 4 (July 2011): 398–408. http://dx.doi.org/10.4161/cib.16716.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Silva, Marcus Tulius T. "Viral encephalitis." Arquivos de Neuro-Psiquiatria 71, no. 9B (September 2013): 703–9. http://dx.doi.org/10.1590/0004-282x20130155.

Full text
Abstract:
While systemic viral infections are exceptionally common, symptomatic viral infections of the brain parenchyma itself are very rare, but a serious neurologic condition. It is estimated that viral encephalitis occurs at a rate of 1.4 cases per 100.000 inhabitants. Geography is a major determinant of encephalitis caused by vector-borne pathogens. A diagnosis of viral encephalitis could be a challenge to the clinician, since almost 70% of viral encephalitis cases are left without an etiologic agent identified. In this review, the most common viral encephalitis will be discussed, with focus on ecology, diagnosis, and clinical management.
APA, Harvard, Vancouver, ISO, and other styles
33

Armitage, John, and Mark Featherstone. "Viral Culture." Cultural Politics 17, no. 1 (March 1, 2021): 1–10. http://dx.doi.org/10.1215/17432197-8797445.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Fowler, James R. "Viral Infections." Hand Clinics 5, no. 4 (November 1989): 613–27. http://dx.doi.org/10.1016/s0749-0712(21)00849-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Ishida, Nakao. "Viral Infections." Nippon Ishinkin Gakkai Zasshi 33, no. 2 (1992): 101–3. http://dx.doi.org/10.3314/jjmm.33.101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Whitley, R. J., and D. W. Kimberlin. "Viral Encephalitis." Pediatrics in Review 20, no. 6 (June 1, 1999): 192–98. http://dx.doi.org/10.1542/pir.20-6-192.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Chien, Jason W., and John L. Johnson. "Viral pneumonias." Postgraduate Medicine 107, no. 1 (January 2000): 67–72. http://dx.doi.org/10.3810/pgm.2000.01.819.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Chien, Jason W., and John L. Johnson. "Viral pneumonias." Postgraduate Medicine 107, no. 2 (January 2000): 67–80. http://dx.doi.org/10.3810/pgm.2000.02.888.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Chien, Jason W., and John L. Johnson. "Viral pneumonias." Postgraduate Medicine 107, no. 3 (January 2000): 41–52. http://dx.doi.org/10.3810/pgm.2000.03.941.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Yoshikai, Yasunobu. "Viral superantigens." Uirusu 43, no. 1 (1993): 119–27. http://dx.doi.org/10.2222/jsv.43.119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Cachopo, João Pedro. "Dialéctica viral." O que nos faz pensar 29, no. 46 (July 15, 2020): 30. http://dx.doi.org/10.32334/oqnfp.2020n46a747.

Full text
Abstract:
Parto de duas perguntas sobre a pandemia de Covid-19. O que revela sobre nós e sobre realidade que nos rodeia? De que modo transforma as nossas formas de vida e a mundo em que vivemos? Do cruzamento das respostas a estas duas perguntas emergem, em tons ora mais optimistas ora mais pessimistas, os possíveis posicionamentos sobre esta crise. Neste artigo, proponho um mapeamento destas respostas (em diálogos com autores como Žižek, Butler, Latour, Klein, Badiou, Nancy, entre outros) ao mesmo tempo que procuro um modo intempestivo de articular as duas perguntas. A hipótese que proponho, apresentada drasticamente, é a de que a pandemia não é o acontecimento. O acontecimento é a transformação das formas de vida (ou a “torção dos sentidos”, como lhe chamo noutro local) que ela já precipita antes de termos a oportunidade de tirar quaisquer conclusões, práticas ou teóricas, sobre o que a pandemia revela sobre o mundo.
APA, Harvard, Vancouver, ISO, and other styles
42

Hamilton, J. R. "Viral Diarrhea." Pediatric Annals 14, no. 1 (January 1, 1985): 25–28. http://dx.doi.org/10.3928/0090-4481-19850101-06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Travis, John. "Viral Survivor." Science News 162, no. 5 (August 3, 2002): 75. http://dx.doi.org/10.2307/4013815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Spinney, Laura. "Going viral." New Scientist 255, no. 3396 (July 2022): 42–45. http://dx.doi.org/10.1016/s0262-4079(22)01312-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Aylward, Frank O., and Mohammad Moniruzzaman. "Viral Complexity." Biomolecules 12, no. 8 (July 30, 2022): 1061. http://dx.doi.org/10.3390/biom12081061.

Full text
Abstract:
Although traditionally viewed as streamlined and simple, discoveries over the last century have revealed that viruses can exhibit surprisingly complex physical structures, genomic organization, ecological interactions, and evolutionary histories. Viruses can have physical dimensions and genome lengths that exceed many cellular lineages, and their infection strategies can involve a remarkable level of physiological remodeling of their host cells. Virus–virus communication and widespread forms of hyperparasitism have been shown to be common in the virosphere, demonstrating that dynamic ecological interactions often shape their success. And the evolutionary histories of viruses are often fraught with complexities, with chimeric genomes including genes derived from numerous distinct sources or evolved de novo. Here we will discuss many aspects of this viral complexity, with particular emphasis on large DNA viruses, and provide an outlook for future research.
APA, Harvard, Vancouver, ISO, and other styles
46

Arora, Neha, and Ashok Wahi. "Viral Marketing." International Journal of Online Marketing 4, no. 1 (January 2014): 52–63. http://dx.doi.org/10.4018/ijom.2014010105.

Full text
Abstract:
The paper explores how viral marketing plays a major role for the companies in the present scenario. This paper gives an insight into the various models to provide an overview into the mathematical aspect associated with viral marketing. At the end the implications of viral marketing on various different industries is discussed. This manuscript elucidates how organizations can design their viral marketing campaigns targeting different types of customers.
APA, Harvard, Vancouver, ISO, and other styles
47

Newnham, David. "Going viral." Nursing Standard 29, no. 21 (January 21, 2015): 27. http://dx.doi.org/10.7748/ns.29.21.27.s32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Febbo, Jennifer, Jonathan Revels, and Loren Ketai. "Viral Pneumonias." Radiologic Clinics of North America 60, no. 3 (May 2022): 383–97. http://dx.doi.org/10.1016/j.rcl.2022.01.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Kühl, Uwe, and Heinz-Peter Schultheiss. "Viral Myocarditis." Drugs 69, no. 10 (July 2009): 1287–302. http://dx.doi.org/10.2165/00003495-200969100-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Gorman, Jessica. "Viral Parts." Science News 161, no. 5 (February 2, 2002): 68. http://dx.doi.org/10.2307/4013174.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Viral' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography